
Stephen N Oesterle MD
Adult Congenital Heart Disease, Interventional Cardiology
Physician
Join to View Full Profile
2855 Sand Hill RoadMenlo Park, CA 94025
Phone+1 650-687-1518
Dr. Oesterle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1981 - 1983
- Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1977 - 1980
- Yale School of MedicineClass of 1977
Certifications & Licensure
- CA State Medical License 1980 - Present
- MA State Medical License 1979 - 2017
- MD State Medical License 1992 - 1993
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 25 citationsLong-Term Marathon Running Is Associated with Low Coronary Plaque Formation in Women.William O. Roberts, Robert S. Schwartz, Stacia Merkel Kraus, Jonathan G. Schwartz, Gretchen Peichel
Medicine and Science in Sports and Exercise. 2017-04-01 - 51 citationsIncreased Coronary Artery Plaque Volume Among Male Marathon Runners.Robert S. Schwartz, Stacia Merkel Kraus, Jonathan G. Schwartz, Kelly Wickstrom, Gretchen Peichel
Missouri Medicine. 2014-03-01 - 26 citationsGranulocyte-macrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps.Sebastian Grundmann, Imo E. Hoefer, Susann Ulusans, Christoph Bode, Stephen N Oesterle
Journal of Vascular Surgery. 2006-06-01
Press Mentions
- Paragon 28® Names Stephen Oesterle, M.D. To Board of DirectorsJanuary 6th, 2021
- HeartWare Expands Board of Directors with Appointment of Stephen N. Oesterle, M.DJanuary 16th, 2016
- Medovex Corporation Announces First DenerveX(TM) System Pre-Production Use in Live Tissue Model (Medovex Corp)January 14th, 2016
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: